Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Breast Cancer Research · 2012
DOI: 10.1186/bcr3165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research, 2012. Verfasst von Daphne SC Lee und 11 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lee, D. S., Yoon, S., Looi, L. M., Kang, P., Kang, I. N., Sivanandan, K., Ariffin, H., Thong, M. K., Chin, K. F., Taib, N. A. M., Yip, C. H., & Teo, S. H. (2012). Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Research. https://doi.org/10.1186/bcr3165
Vancouver
Lee DS, Yoon S, Looi LM, Kang P, Kang IN, Sivanandan K, et al. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Research. 2012. doi:10.1186/bcr3165
BibTeX
@article{Lee2012,
author = {Lee, Daphne SC and Yoon, Sook-Yee and Looi, Lai Meng and Kang, Peter and Kang, In Nee and Sivanandan, Kavitta and Ariffin, Hany and Thong, Meow Keong and Chin, Kin Fah and Taib, Nur Aishah Mohd and Yip, Cheng Har and Teo, Soo Hwang},
title = {Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients},
journal = {Breast Cancer Research},
year = {2012},
doi = {10.1186/bcr3165}
}
EUVIMED